TSUMURA USA, INC. is a company based in Princeton, New Jersey, that specializes in the development of Kampo herbal medicines.
At present, Daikenchuto (Product Code: TU-100), Tsumura's flagship investigational Kampo medication, is being developed in the US and is undergoing clinical trials to assess its safety and efficacy for the treatment of postoperative ileus.
- Company Name:
- TSUMURA USA, INC.
- Establishment:
- August, 2001
- Office Address:
- 202 Carnegie Center, Suite 306, Princeton, New Jersey 08540
- Shareholder:
- 100 % - owned subsidiary of Tsumura & Co. (Tokyo, Japan)
